Biopharmaceutical Cold Chain Third Party Logistics Market Set to Reach $74.46 Bn by 2033

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Cold Chain Third Party Logistics Market Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. The global biopharmaceutical cold chain third party logistics market size was estimated at USD 30.59 billion in 2024 and is projected to reach USD 74.46 billion by 2033, growing at a CAGR of 10.54% from 2025 to 2033. This market growth is due to the rising demand for temperature-sensitive pharmaceuticals, stringent drug storage and transportation regulatory requirements, and the global expansion of biologics and vaccine distribution. In addition, increasing outsourcing of logistics services by pharmaceutical companies is further driving market expansion. Furthermore, increasing demand for biologics, vaccines, and temperature-sensitive drugs has significantly expanded the need for reliable cold chain logistics solutions. Biologics, including monoclonal antibodies, gene therapies, and recombinant proteins, require stringent temperature control, typically between 2C and 8C, with some requiring ultra-low storage at -70C or lower-to maintain their efficacy. Moreover, the growing trend towards personalized medicine has further boosted the need for specialized logistics solutions to ensure product integrity throughout the supply chain. This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global biopharmaceutical cold chain third party logistics market based on service, temperature range, and region. Why You Should Buy This Report Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments. Competitive Landscape: Explore the market presence of key players. Future Trends: Discover the pivotal trends and drivers shaping the future of the market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. Key Attributes: Report AttributeDetailsNo. of Pages150Forecast Period2024 - 2033Estimated Market Value (USD) in 2024$30.59 BillionForecasted Market Value (USD) by 2033$74.46 BillionCompound Annual Growth Rate10.5%Regions CoveredGlobal Market Variables, Trends, & Scope Market Lineage Outlook Parent Market Outlook Related/Ancillary Market Outlook Market Trends and Outlook Market Dynamics Market Driver Analysis Market Restraint Analysis Technological Landscape Pricing Model Analysis Industry Analysis Tools Porter's Five Forces Analysis PESTEL Analysis COVID-19 Impact Analysis Companies Featured Cardinal Health DHL Group Agility SF Express Kinesis Medical B.V. United Parcel Service of America, Inc. Barrett Distribution Cencora DB Schenker FedEx KUEHNE + NAGEL Kerry Logistics Network Ltd. Freight Logistics Solutions Global Biopharmaceutical Cold Chain Third Party Logistics Market Report Segmentation Services Outlook (Revenue, USD Million, 2021-2033) Transportation Warehousing & Storage Packaging Solutions Monitoring & Visibility Solutions Inventory Management Others Temperature Range Outlook (Revenue, USD Million, 2021-2033) Frozen Ultra-frozen/Deep-Frozen Cryogenic Regional Outlook (Revenue, USD Million, 2021-2033) North America Europe Asia-Pacific Latin America Middle East & Africa For more information about this report visit https://www.researchandmarkets.com/r/kf5gk4 About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Biopharmaceutical Cold Chain Third Party Logistics Market